CLINICAL_TRIALS
research
· 2015-07-07
Clinical Trial Update: CIK in Treating Patients With Esophageal Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating cytokine-induced killer cells for esophageal squamous cell carcinoma is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The First People's Hospital of Changzhou | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING